Amarin Corporation is a drug manufacturers - general business based in the US. Amarin Corporation shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Amarin Corporation employs 275 staff and has a trailing 12-month revenue of around $277.5 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.78 |
|---|---|
| 52-week range | $0.63 - $1.37 |
| 50-day moving average | $0.78 |
| 200-day moving average | $0.89 |
| Wall St. target price | $1.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.13 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.7844 from 2024-07-24
| 1 week (2024-07-18) | -0.70% |
|---|---|
| 1 month (2024-06-25) | 7.70% |
| 3 months (2024-04-25) | -8.80% |
| 6 months (2024-01-25) | -37.75% |
| 1 year (2023-07-25) | -30.58% |
|---|---|
| 2 years (2022-07-25) | -41.46% |
| 3 years (2021-07-25) | 4.39 |
| 5 years (2019-07-25) | 18.49 |
| Revenue TTM | $277.5 million |
|---|---|
| Gross profit TTM | $260.6 million |
| Return on assets TTM | -1.96% |
| Return on equity TTM | -9.31% |
| Profit margin | -18.96% |
| Book value | $1.33 |
| Market Capitalization | $320.5 million |
TTM: trailing 12 months
We're not expecting Amarin Corporation to pay a dividend over the next 12 months.
Amarin Corporation's shares were split on a 1:10 basis on 17 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin Corporation shares which in turn could have impacted Amarin Corporation's share price.
Over the last 12 months, Amarin Corporation's shares have ranged in value from as little as $0.6271 up to $1.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin Corporation's is 1.96. This would suggest that Amarin Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co. , Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.